Amendia said Tuesday it acquired New Jersey-based spinal technology company Custom Spine. Amendia did not disclose the details of the acquisition.
Marietta, Ga.-based Amendia said the acquisition would further its focus on the spinal market and that Custom Spine’s Pathway articulating vertebral interbody technology was of specific interest to Amendia.
“I’m looking forward to adding Custom Spine’s technologies to Amendia’s comprehensive product offering. Custom Spine’s rich IP portfolio, engineering know-how, skilled sales force, and customer base makes this transaction an easy fit for both companies. Custom Spine brings the rights to 40 patents to Amendia, which instantaneously increases the breadth and depth of our R&D pipeline. This is very exciting for the company and also for patient care,” Amendia CEO Jeff Smith said in a press release.
The Pathway AVID provides structural support during spinal fusions, and includes 3 intra-linked Peek cages, inserted with a standard transforaminal procedure, and provides sequential articulation to each segment.
“The business combination of Amendia and Custom Spine brings together 2 highly complementary companies. It creates an organization uniquely qualified to meet the needs of today’s ever-evolving healthcare market, to the benefit of patients, surgeons, distributors, hospitals, and payers,” Custom Spine CEO Mahmoud Abdelgany said in prepared remarks.
Last month, Amendia acquired transforaminal lumbar interbody fusion system assets from SpineSelect. The system assets purchased by Amendia include 2 product families – the Marquise MIS channel system and the Turbo MIS TLIF system, the Marietta, Ga.-based company said.
Amendia gained a total of 20 spinal technology patents from SpineSelect, the company said.